DocGo Inc. (DCGO)
| Market Cap | 56.80M -59.4% |
| Revenue (ttm) | 301.71M -42.0% |
| Net Income | -187.76M |
| EPS | -1.91 |
| Shares Out | 98.78M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 987,340 |
| Open | 0.6210 |
| Previous Close | 0.6342 |
| Day's Range | 0.5710 - 0.6210 |
| 52-Week Range | 0.4511 - 1.7590 |
| Beta | 0.99 |
| Analysts | Buy |
| Price Target | 1.88 (+226.96%) |
| Earnings Date | Aug 17, 2026 |
About DCGO
DocGo Inc. operates as a mobile healthcare services company in the United States and the United Kingdom. It operates through Mobile Health Services and Transportation Services segments. The company offers transportation services comprising emergency response services; and non-emergency transport services, such as ambulance and wheelchair transportation services. It also provides mobile health services through its care delivery platform that are performed at home, offices, and other locations comprising mobile urgent care, exams, vaccinations, m... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for DCGO stock is "Buy." The 12-month stock price target is $1.88, which is an increase of 226.96% from the latest price.
News
Did DocGo Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
DocGo Transcript: AGM 2026
The meeting covered board transitions, approval of key proposals, and strong financial performance, including record growth in core business lines and successful acquisitions. Strategic initiatives focus on technology-driven efficiency and integrated care, with ongoing exploration of shareholder value alternatives.
DocGo Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026
The business has shifted from emergency response to a scalable, technology-driven healthcare delivery model, focusing on in-home, virtual, and transportation services. Integration of SteadyMD and the Care Anywhere platform is driving efficiency, margin improvement, and growth, while regulatory changes and payer partnerships support a path to profitability and long-term expansion.
DocGo launches mobile phlebotomy services in South Florida
DocGo (DCGO) announced that its PTI Health by DocGo subsidiary has launched mobile phlebotomy services in Southern Florida. In conjunction with this launch, PTI Health has expanded its relationship wi...
DocGo Launches Mobile Phlebotomy Services in South Florida
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced that its PT...
DocGo Announces Upcoming Participation at the Goldman Sachs 47th Annual Global Healthcare Conference
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health and medical transportation services, today announced that Lee Bienstock, Chief Ex...
DocGo Transcript: 21st Annual Needham Technology, Media, & Consumer Conference
The conference highlighted strong growth in tech-driven mobile healthcare, with significant expansion in medical transportation and care in the home. Financial guidance was raised, with a clear path to profitability, and operational improvements are underway. The company is leveraging technology and strategic partnerships to drive efficiency and growth.
DocGo reports Q1 EPS (15c), two estimates (6c)
Reports Q1 revenue $75.6M, consensus $72.4M. Lee Bienstock, Chief Executive Officer of DocGo (DCGO), commented, “We continued to experience strong volumes across all key business verticals, and especi...
DocGo Earnings Call Transcript: Q1 2026
Q1 2026 saw $75.6M revenue and strong growth in virtual care and medical transportation, offset by higher labor and fuel costs. 2026 revenue guidance was raised to $300M-$315M, with margin improvement expected as cost cuts take effect.
DocGo Earnings release: Q1 2026
DocGo released its Q1 2026 earnings on May 11, 2026, summarizing the period's financial results.
DocGo Quarterly report: Q1 2026
DocGo has published its Q1 2026 quarterly earnings report on May 11, 2026.
DocGo Announces First Quarter 2026 Results
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial a...
DocGo Announces Upcoming Participation at the 21st Annual Needham Technology, Media, & Consumer Conference
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled medical transportation and mobile health services, announced today that Lee Bienstock, Chief Ex...
DocGo to Announce First Quarter 2026 Results on Monday, May 11, 2026
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled medical transportation and mobile health services, announced today that the Co...
DocGo Proxy statement: Proxy filing
DocGo filed a proxy statement on April 22, 2026, providing details for shareholder voting and corporate governance matters.
DocGo Proxy statement: Proxy filing
DocGo filed a proxy statement on April 22, 2026, providing details for shareholder voting and corporate governance matters.
DocGo Proxy statement: Proxy filing
DocGo filed a proxy statement on April 10, 2026, providing details for shareholder voting and corporate governance matters.
DocGo Slides: Investor presentation
DocGo has posted slides in relation to its latest quarterly earnings report, which was published on March 25, 2026.
DocGo price target lowered to $1 from $1.50 at Canaccord
Canaccord lowered the firm’s price target on DocGo (DCGO) to $1 from $1.50 and keeps a Hold rating on the shares. The firm updated is model following mixed Q4 results…
Ethisphere Names DocGo as One of the 2026 World's Most Ethical Companies®
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled medical transportation and mobile health services, announced today that it has...
DocGo price target lowered to $2.50 from $4 at Stifel
Stifel lowered the firm’s price target on DocGo (DCGO) to $2.50 from $4 and keeps a Buy rating on the shares. Q4 results were mixed and 2026 guidance was raised…
DocGo Earnings Call Transcript: Q4 2025
Q4 2025 revenue exceeded expectations at $74.9M, but adjusted EBITDA loss was $11.6M due to non-recurring costs. 2026 guidance was raised, with revenue expected at $290M-$310M and adjusted EBITDA loss narrowed to $5M-$10M, driven by growth in SteadyMD and medical transportation.
DocGo Annual report: Q4 2025
DocGo has published its Q4 2025 annual report on March 16, 2026.
DocGo Earnings release: Q4 2025
DocGo released its Q4 2025 earnings on March 16, 2026, summarizing the period's financial results.
DocGo reports FY25 EPS ($1.84), two estimates (60c)
Reports Q4 revenue $74.9M, consensus $70.4M. Lee Bienstock, Chief Executive Officer of DocGo (DCGO), commented “While 2025 was a year of transition and focus on our core business lines, the…